BBC News menu Covid: Rapid tests 'useful public health

New Post Public Reply Private Reply Replies (1) Message Board
Crunch55
338
BBC News
menu
Covid: Rapid tests 'useful public health tool'
By Rachel Schraer
Health reporter
23 December 2020 Health
Share this with Email Share this with Facebook Share this with Twitter Share this with Whatsapp
Image copyrightGETTY IMAGESlateral flow testing site
Rapid tests for coronavirus are a "useful" public health tool despite only picking up half as much virus as tests done in a lab, a group of scientists has said.

The 30-minute test has been criticised for how it measures up to the tests processed in the government's mega-labs.

But the scientists cautioned against comparing them directly.

The tests serve different purposes in different contexts, they explained.

And rapid tests may be a better guide to who is currently infectious.

During a testing pilot in Liverpool, the devices picked up two-thirds of the most infectious cases - all people who would not have otherwise been tested at all.

The pilot, which made tests available to anyone in the city who wanted one, picked up 1,300 infections in people without symptoms in a population of about half a million.

Prof Louise Kenny at the University of Liverpool said even if one in three infections was missed, that left two infections which would not otherwise have been found.

No test was perfect, she said, but she warned against "making perfection the enemy of the good".

However, the evaluation of the Liverpool pilot found there was "no clear evidence that the introduction of 'mass' testing in Liverpool impacted on Covid-19 cases or hospital admissions."

The scientists on the panel included those involved in evaluating rapid tests in Liverpool, Oxford and the Porton Down research facility.

Pros and cons of PCR and lateral flow
Standard lab tests, also known as PCR tests, pick up some infections that rapid or "lateral flow" tests miss, particularly in the early stages of infection.

These are the tests you'll have if you have symptoms.

PCR tests are very important for use in diagnosing people - by the time someone turns up at a hospital they may not have much virus in their nose or throat, as it migrates to the lungs. So in these situations having a very sensitive test is useful.

They are crucial for use in surveillance of the virus, and they're also important for contact-tracing since, even if that individual is no longer infectious, they may have passed it on to others who are.

But the downside is they pick up small fragments of inactive virus, meaning some people might be told to isolate when they are no longer capable of infecting anyone.

Rapid or lateral flow tests, on the other hand, are not good at picking up relatively small amounts of virus.

Overall, the Liverpool study found the devices only picked up 40% of cases - less than expected.

This means the tests will miss people in the day or two before they are about to become infectious, as well as those who have cleared the infection from their systems.

rapid tests miss infectious and dead virus - line chart
But they do find the majority of the most infectious cases - and lateral flow tests have the major advantage of not needing to be taken to a lab.

They work by dipping a nose and throat swab in special solution and then dropping that fluid onto a plastic stick a bit like a pregnancy test.

"The time and scale gained by having a low-cost test that returns results within an hour without a laboratory is a valuable new tool for tackling Covid-19," according to Prof Iain Buchan, who led the Liverpool evaluation.

This allows for many more people to access testing, including those without symptoms - people for whom it is "this or nothing", Prof Kenny said.

Context is key
Screening asymptomatic people in the community is potentially nothing but positive, provided people don't change their behaviour after a negative result - and isolate after a positive one.

It's a more difficult question once you are using them to clear people to do something - for example visit a care home resident or cross the border into France .

Missing perhaps a third of infections - although it can be less if the test is done by a trained person - might be too high a risk in those cases.

But even if you are allowing someone to do something they wouldn't have otherwise, the tests can allow people to balance risk with harm.

They might provide reassurance to allow someone in a care home who has been deprived of social contact to have a visitor wearing PPE.

Or, if there is one Covid case in a school year, it could be used to prevent a whole class from having to isolate and miss face-to-face education.

They don't eliminate risk, but they can reduce it in situations where there is enough benefit.

And their accuracy can be improved by screening people regularly, Prof Kenny explained - perhaps once or twice a week in schools, universities and specific workplaces.

Prof Jacqui Ramagge, who led student testing efforts at the University of Durham, said "the chances of someone being positive when they are repeatedly testing negative is very, very low".

Follow Rachel on Twitter

Copyright © 2020 BBC. The BBC is not responsible for the content of external sites.

Quantum Materials Corp. (QTMM) Stock Research Links

QTMM Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aroa Biosurgery Reports Low Infection Rates: A Milestone

Updated Category News Views 2

Peer-Reviewed Study: Aroa's Myriad Shows Low Infection Rates Seems like the folks at Aroa Biosurgery have got something solid to brag about in the world of complex soft tissue reconstruction. The company just released interim results from their massive MASTRR Registry study, and the numbers are looking pretty darn promising. We're talking about a 411-patient analysis...

Continue Reading
Clover's RSV Combo Vaccine Shows Promise in Trials

Updated Category News Views 4

In the biotech world, there's always a race. Clover Biopharmaceuticals is making strides with their RSV+hMPV vaccine candidate, especially for the elderly. Imagine those big leaps in development—all boosted by recent results from a Phase 2 trial down under in Australia. Key Findings of the Trial Immunogenicity Insights They're not messing around with these findings. The...

Continue Reading
EyePoint Stumbles: Legal Eagles Circle Post-Trial Flop

Updated Category News Views 2

EyePoint Slips on Clinical Banana Peel Well, if EyePoint was aiming for a splash, they sure got it—just not the kind they were hoping for. News dropped like a lead balloon when EyePoint announced their Phase 3 DURAVYU trial results for wet age-related macular degeneration, revealing they missed their primary endpoint. And what did that mean for their stock? A death...

Continue Reading
Media Forum Spotlights Asia-Pacific Cooperation

Updated Category News Views 3

The Opening Scene: A Gathering with Purpose Well, here we go, diving right into the latest shindig in Shenzhen at the Asia-Pacific Media Forum. Held in China's Guangdong province, they've rounded up over 400 reps from every corner of the globe, all chewing over one key theme: "Building a Path to Shared Prosperity for the Asia-Pacific Community." You could say it's a step...

Continue Reading
Bad Bunny Super Bowl Halftime Show Sweeps 7 Emmy Wins

Updated Category News Views 6

An Unprecedented Performance: A Halftime Show for the Ages Hold onto your hats, folks—Bad Bunny and his Super Bowl LX Halftime Show have taken home a jaw-dropping seven Emmys at the 78th Emmy Awards. This is uncharted territory for any Super Bowl Halftime Show. Never before has a halftime spectacle swept the Emmys like this. We’re talking about categories such as...

Continue Reading
Midea's VitaBreeze: Revolutionizing Personalized Climate

Updated Category News Views 7

A Fresh Breeze in Climate Control Here's something that'll shake up your household. Midea just announced their latest gizmo, called VitaBreeze, and they’re not messing around. They introduced it at IFA 2026, promising it's not just for cooling off in the summer or heating in the winter. Oh no, my friends, they've packed this unit with enough cutting-edge tech that...

Continue Reading
Zendure, SolarFlow Pro Win Big at IFA 2026 Tech Awards

Updated Category News Views 2

Trophy Time for Zendure in Berlin The Berlin Chronicles of 2026 tell an interesting tale for Zendure—a tale where top honors and glowing recognition highlight its efforts in the sustainable energy arena. At the Global Product Technology Innovation Awards, Zendure's SolarFlow 4000 Mix Pro snagged the Gold for Sustainable Home Energy Storage System. Not only that, but...

Continue Reading
ATTACK SHARK Partners with Cloud9 League Team

Updated Category News Views 2

Shaking Hands with Cloud9 ATTACK SHARK is jumping headfirst into the esports game, teaming up with Cloud9's League of Legends team. Now, before you roll your eyes at another corporate matchmaking play, consider the magic at play here. League of Legends isn't just any game; it's a titan in the esports universe, and partnering with Cloud9 offers a serious boost. It's not...

Continue Reading
Summit Tackles BRI Infrastructure's Role in Global SDGs

Updated Category News Views 3

A Bold Gathering with Lofty Goals Ever watch a room of world leaders debate the finer nuances of sustainable infrastructure? That's something Singapore pulled off on September 6, 2026, with the Second Global Business Summit on Belt and Road Infrastructure Investment. These aren't just any ordinary suits sitting around in a conference room. We're talking about a dynamic...

Continue Reading

Top 5 Most Recently Viewed Articles

MarketVector Indexes Unveils MAGA10 Index for Crypto Investors

Updated Category News Views 429

MarketVector Indexes Introduces MAGA10 Index for Crypto Enthusiasts MarketVector Indexes™, a prominent name in the world of digital asset indices, recently made headlines by launching the MAGA10 Index. This innovative benchmark is specifically designed to reflect the performance of significant and liquid crypto assets that are based in the U.S. The introduction of this...

Continue Reading
Understanding the Rise in Antero Resources' Short Interest

Updated Category News Views 103

An Overview of Antero Resources' Short Interest Recently, it was reported that Antero Resources Corp (NYSE: AR) has experienced a rise in its short interest. Specifically, the short percent of the float has increased by 5.22%, bringing the total shares sold short to approximately 9.35 million. This figure accounts for about 3.83% of all available shares for trading....

Continue Reading
Smoothie King's Innovative Run-Thru Experience Launch

Updated Category News Views 425

Exciting New Initiatives from Smoothie King to Engage Runners Smoothie King, the leading smoothie brand, is celebrating Global Running Day with exciting initiatives that encourage healthy and active lifestyles. Among these initiatives is the unveiling of their innovative Run-Thru concept, featuring a special event that emphasizes convenience for runners. This...

Continue Reading
Germany's FDI Sees Slight Dip Amid Global Slowdown

Updated Category News Views 7

Germany's FDI: Holding Ground Amid Global Turbulence In a world where economic stability feels rare as a three-legged unicorn, Germany's 2025 foreign direct investment (FDI) figures show a semblance of resilience. Sure, there’s been a 9.3% decline in FDI projects, but when the world seems to be stumbling around, even a stumble’s notable. According to Germany Trade &...

Continue Reading
Exciting New Designs for USPS 2026 Priority and Express Stamps

Updated Category News Views 161

USPS Unveils New 2026 Priority and Express Stamps The United States Postal Service has exciting news for stamp collectors and enthusiasts as it presents its new Priority Mail and Priority Mail Express stamps set to debut in 2026. These new designs reflect the Postal Service's commitment to creativity and customer engagement through captivating themes that celebrate...

Continue Reading